Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy: a Nationwide Randomized Controlled Trial

NCT04875325 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04875325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04875325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy: a Nationwide Randomized Controlled Trial
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 16, 2021
Completion date
October 31, 2026
Enrollment
306 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pancreatic ductal adenocarcinoma, resectable pancreatic ductal adenocarcinoma